
|Articles|January 20, 2022
Daily Medication Pearl: Cyclosporine Ophthalmic Solution (Cequa)
Author(s)Saro Arakelians, PharmD
Cequa ophthalmic solution is indicated to increase tear production in patients with dry eyes.
Advertisement
Medication Pearl of the Day: Cyclosporine ophthalmic solution (Cequa)
Indication: Cequa ophthalmic solution is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients with keratoconjunctivitis sicca (dry eyes).
Insight:
- Dosing: Instill 1 drop of Cequa twice daily (approximately 12 hours apart) into each eye. Discard the vial immediately after using in both eyes.
- Dosage forms: Ophthalmic solution containing cyclosporine 0.9 mg/mL.
- Adverse events (AEs): The most common AEs reported in greater than 5% of subjects were pain on instillation of drops (22%) and conjunctival hyperemia (6%). Other AEs reported in 1% to 5% of the patients were blepharitis, eye irritation, headache, and urinary tract infection.
- Mechanism of action: Cyclosporine is a calcineurin inhibitor immunosuppressant agent when administered systemically.
- Manufacturer: Sun Pharma
Sources:
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Pharmacists Should Know About Novo Nordisk-Eli Lilly GLP-1 Ad Suit
2
Overlooked Coronavirus Protein May Drive Cytokine Storm, Cardiac Injury in Severe COVID-19
3
FDA Grants Fast Track Designation to ERAS-0015 for Metastatic Pancreatic Cancer
4
Biosimilars: A Guide for Pharmacists
5


































































































